Diagnostics North East Conference 2019

Supporting early stage development to clinical adoption

11 April 2019

Venue: International Centre for Life, Newcastle upon Tyne

Aim of the Conference

This conference will showcase the diagnostic resources and expertise available to support researchers, clinicians, and industry in developing and deploying new and innovative diagnostic technologies. The event will provide opportunities to meet with key experts and to discuss how they can support the development, evaluation and adoption of technologies into healthcare systems. The event will provide the delegates with the information they need to partner and exploit the world-class resources available.

Register here

Thursday 11th April


09:00     Registration and Networking


10:00 – 10:10    Welcome and Introduction to Diagnostics North East

Opening keynote speakers


10:10 – 10:40   

Dr Michael Dalrymple, Executive Director, Diagnostics & Science Foresight, LifeArc


10:40 – 11:00 

Doris-Ann Williams (BIVDA), Chief Executive, BIVDA


11:00-11:15

Refreshment Break


11:15-12:30

Workshop Session 1 (2 x 30 minute sessions per workshop):

Diagnostic laboratory medicine and pathology (Molecular Pathology Node)

The workshop will highlight Node capabilities in tissue-based techniques and technical aspects of immunostaining alongside providing an overview of our competence in digital imaging and Artificial Intelligence and an illustration of our successful commercial collaborations to date

What Newcastle Biobanks have to offer and why ‘collect to order’ works for the CEPA Biobank’

The workshop will include a brief breakdown of: history; scope; our Biobanks ethics; types of specimens; processing; and how to access the Biobanks

Evaluating Technologies (MIC/EAC)

The workshop will describe the expertise within the Diagnostics North East (DxNE) initiative that can support academics and companies with evidence generation needed for NHS adoption.  The workshop introduces the National Institute for Health Research (NIHR) Newcastle In Vitro Diagnostics Co-operative (Newcastle MIC), who work closely with technology developers to ensure that their product has the right evidence to demonstrate its value to the NHS, and the National Institute for Health and Care Excellence (NICE) External Assessment Centre (EAC), who evaluate that evidence on behalf of NICE.


12:30 – 12:50 NIHR Newcastle MIC Industry Showcase – Roche RSV study

Dr Malcolm Brodlie, MRC Clinician Scientist and Clinical Senior Lecturer, Institute of Cellular Medicine, Newcastle University
Honorary Consultant in Paediatric Respiratory Medicine, Great North Children's Hospital


12:50 – 13:00 Announcement of the upcoming launch of Therapeutics North East

Neil Watson, Director of Pharmacy, The Newcastle upon Tyne Hospitals NHS Foundation Trust


13:00 – 14:00  Lunch and Networking


14:00 – 15:15 Workshop Session 2 (2 x 30 minute sessions per workshop):

AHSN North East and North Cumbria

Innovation Exchange and Adoption

CRN North East and North Cumbria and MedConnect North

Centre for Process Innovation (CPI)

Adoption of your medtech product by healthcare systems is the ultimate goal. The successful development of a medical device can be optimised through carefully managed design and development.   During this workshop we will cover critical components on the development path of your medtech from your idea to adoption.    Discussion will be focussed up best practice on designing for manufacture, use of additive manufacturing, compliance with relevant regulations, and testing and validation of your device.


15:15 – 15:30  

Professor Amar Rangan, Professor of Orthopaedic Surgery, James Cook University Hospital


15:30 – 15:45  Supporting Innovation and Adoption of Diagnostics

Dr Séamus O’Neill, Chief Executive Officer, AHSN NENC


Closing keynote speaker


15:45 – 16:15 

Dr Vicky McFarlane Reid, Director of Research and Development, Leica Biosystems


 

16:15 – 16:30 Final Q&A and close of conference